Xin Hua Wang·2025-08-12 05:48Group 1 - Multiple listed companies have proposed share buybacks to bolster market confidence [1][2][3] - Yifan Pharmaceutical plans to repurchase shares at a price not exceeding 20.57 CNY per share, with a total buyback amount between 30 million CNY and 50 million CNY [1] - Ruilian New Materials intends to buy back shares with a total amount between 50 million CNY and 80 million CNY, at a price not exceeding 51 CNY per share [1] - Kairda plans to repurchase shares with a total amount between 50 million CNY and 60 million CNY, with a price cap based on the average trading price [2] - Sike Rui proposes a buyback with a total amount between 30 million CNY and 50 million CNY, at a price not exceeding 80 CNY per share [2] - Longxin Zhongke also plans a buyback with a total amount between 30 million CNY and 50 million CNY, at a price not exceeding 128 CNY per share [2] Group 2 - Biyi Micro plans to repurchase shares with a total amount between 42 million CNY and 84 million CNY, at a price not exceeding 78 CNY per share [3] - Dongjian Technology's major shareholder plans to increase holdings between 10 million CNY and 20 million CNY without a price range [3] - Bangjie shares have adjusted their planned increase in holdings from 30 million CNY to 60 million CNY to a new range of 35 million CNY to 70 million CNY [3] Group 3 - The effectiveness of these buyback and increase plans in attracting investor interest remains uncertain, as seen with Dongjian Technology's recent share reduction plans [4] - Dongjian Technology's shareholders have previously reduced their holdings by 6.15 million shares, representing 1.46% of total shares, and have announced new reduction plans [4]